Certified by Founder Lodge
Qiming Venture Partners USA
United States - Seattle, Washington
INVESTOR
1 Disclosed Funding Rounds $25,000,000
7 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
We know how companies can and should be built.
Founded in 2017, Qiming Venture Partners USA is a healthcare venture capital firm and healthcare investor with a combination of deep technica
| Company | Date | Round | Raised |
|---|---|---|---|
 Soda Health |
September, 14 ,2022 | Series A | $25,000,000 |
 Allorion Therapeutics |
March, 13 ,2023 | Series B | $50,000,000 |
 Abdera Therapeutics |
April, 24 ,2023 | Series B | $142,000,000 |
 LTZ Therapeutics |
June, 01 ,2023 | Pre Series A | $10,000,000 |
 Candid Therapeutics |
September, 10 ,2024 | Unknown | $370,000,000 |
 Umoja Biopharma |
January, 21 ,2025 | Series C | $100,000,000 |
 Rhino Federated Computing |
May, 23 ,2025 | Series A | $15,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
